AMENDED AND RESTATED PRODUCTS DEVELOPMENT AGREEMENTProducts Development Agreement • November 5th, 2008 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2008 Company Industry JurisdictionThis Amended and Restated Products Development Agreement (this “Agreement”) is made and dated as of December 29, 2006 (the “Effective Date”), and amended and restated as of the 27th day of August, 2008, by and between Cornerstone Biopharma, Inc., a Nevada corporation (“Cornerstone”), and Neos Therapeutics, L.P., a Texas limited partnership (“Neos”) (Cornerstone and Neos are sometimes referred to herein individually as a “Party” and collectively as the “Parties”).
ADDENDUM TO AMENDED AND RESTATED PRODUCTS DEVELOPMENT AGREEMENTProducts Development Agreement • August 5th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledAugust 5th, 2010 Company IndustryThis Addendum to the Amended and Restated Products Development Agreement (this “Addendum”) is made and dated as of May 31, 2010 (the “Effective Date”), by and between Cornerstone Therapeutics Inc., a Delaware corporation (“Cornerstone”), and Neos Therapeutics, L.P., a Texas limited partnership (“Neos”) (Cornerstone and Neos are sometimes referred to herein individually as a “Party” and collectively as the “Parties”).